1.
Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers. Hematol Meeting Rep [Internet]. 2009 Jun. 10 [cited 2025 Jul. 4];2(13). Available from: https://journals.pagepress.org/hmr/article/view/482